Page last updated: 2024-11-01

nitroglycerin and Bone Loss, Osteoclastic

nitroglycerin has been researched along with Bone Loss, Osteoclastic in 5 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jamal, SA1
Hamilton, CJ1
Eastell, R1
Cummings, SR1
Khosla, S1
Wimalawansa, SJ2
Chapa, MT1
Yallampalli, C1
Zhang, R1
Simmons, DJ1
Hayashi, T1
Ito, I1
Kano, H1
Endo, H1
Iguchi, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Nitrates and Bone Turnover (NABT): Trial to Select the Best Nitrate Preparation[NCT01387672]Phase 3265 participants (Actual)Interventional2011-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Bone Turnover Markers

"Markers of Bone Formation:~Serum Procollagen type 1 amino- terminal propeptide (P1NP)~Serum Osteocalcin (OC)~Serum Bone-specific alkaline phosphatase (BALP)~Markers of Bone Resorption:~- Serum C-telopeptides of collagen cross-links (CTX)" (NCT01387672)
Timeframe: 3 months

,,,,,
InterventionPercent change from baseline (Mean)
P1NPOCBALPCTX
0.3 Sublingual (Nitrostat 1) - Treatment Arm 4-6.1261.046-7.000-0.666
0.6 Sublingual (Nitrostat 2) - Treatment Arm 52.9411.033-3.686-1.380
ISMO - Treatment Arm 1-4.627-3.244-5.023-5.844
Ointment (Nitrol) - Treatment Arm 3-4.297-4.481-7.426-9.699
Patch (Nitro-Dur) - Treatment Arm 2-0.4053.796-0.541-1.025
Placebo Ointment - Treatment Arm 6-1.6354.247-1.648-1.783

Headache

"Severity of headaches. Subjects recorded the severity of headaches upon awakening every day during the run-in phase using a visual analogue scale (VAS). The scale is represented by a line (continuum) 10 cm long. Subjects were asked to make a vertical line along the continuum to indicate the severity of their headache each morning upon awakening. The score is recorded in cm from 0 to 10. A vertical line marked at 0 means no headache (score recorded = 0), a vertical line marked at 10 means a terrible headache (score recorded = 10)." (NCT01387672)
Timeframe: Run-in phase - 2 days

Interventionscore on a scale (Mean)
ISMOPatchOintment0.3 Sublingual0.6 Sublingual
Run-in Phase2.13.11.50.360.6

Trials

3 trials available for nitroglycerin and Bone Loss, Osteoclastic

ArticleYear
Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.
    JAMA, 2011, Feb-23, Volume: 305, Issue:8

    Topics: Administration, Topical; Aged; Bone Density; Bone Density Conservation Agents; Bone Resorption; Doub

2011
Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2000, Volume: 55, Issue:4

    Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Density; Bone Resorption; Brachial Artery; Endothelium

2000
Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2000, Volume: 15, Issue:11

    Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Resorption; Collagen; Collagen Type I; E

2000

Other Studies

2 other studies available for nitroglycerin and Bone Loss, Osteoclastic

ArticleYear
Is nitroglycerin a novel and inexpensive treatment for osteoporosis?
    JAMA, 2011, Feb-23, Volume: 305, Issue:8

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Female; Fractures, Bone; H

2011
Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats.
    Bone, 1997, Volume: 21, Issue:3

    Topics: Absorptiometry, Photon; Animals; Bone Density; Bone Resorption; Femur; Male; Methylprednisolone; NG-

1997